Shifa
Jebari
Publicaciones en las que colabora con Shifa Jebari (12)
2024
-
Aterosklerosiaren fisiopatologia: disfuntzio endotelialetik plakaren hausturara
Osagaiz: osasun-zientzien aldizkaria, Vol. 8, Núm. 1, pp. 119-132
-
OptiMo-LDLr: An Integrated In Silico Model with Enhanced Predictive Power for LDL Receptor Variants, Unraveling Hot Spot Pathogenic Residues
Advanced Science, Vol. 11, Núm. 13
2023
-
Predictive Modeling and Structure Analysis of Genetic Variants in Familial Hypercholesterolemia: Implications for Diagnosis and Protein Interaction Studies
Current Atherosclerosis Reports, Vol. 25, Núm. 11, pp. 839-859
2021
-
MLb-LDLr: LDLaren hartzailearen aldaeren eragina aurresatekoikasketa automatikoko eredua
Osasun zientzak: IV. Ikergazte Nazioarteko Ikerteta Euskaraz. 2021eko ekainaren 9, 10 eta . Gasteiz, Euskal Herria.
2020
-
Cholesterol efflux efficiency of reconstituted HDL is affected by nanoparticle lipid composition
Biomedicines, Vol. 8, Núm. 10
-
Hiperkolesterolemia Familiarra: patofisiologia, diagnostikoa eta tratamendua
Osagaiz: osasun-zientzien aldizkaria, Vol. 4, Núm. 1, pp. 69-80
-
Mutation type classification and pathogenicity assignment of sixteen missense variants located in the EGF-precursor homology domain of the LDLR
Scientific reports, Vol. 10, Núm. 1, pp. 1727
-
Pathophysiology of type 2 diabetes mellitus
International Journal of Molecular Sciences, Vol. 21, Núm. 17, pp. 1-34
-
Statin treatment-induced development of type 2 diabetes: From clinical evidence to mechanistic insights
International Journal of Molecular Sciences, Vol. 21, Núm. 13, pp. 1-25
2019
-
The Arg499His gain-of-function mutation in the C-terminal domain of PCSK9
Atherosclerosis, Vol. 289, pp. 162-172
2018
-
Replacement of cysteine at position 46 in the first cysteine-rich repeat of the LDL receptor impairs apolipoprotein recognition
PLoS ONE, Vol. 13, Núm. 10
-
p.(Asp47Asn) and p.(Thr62Met): non deleterious LDL receptor missense variants functionally characterized in vitro
Scientific Reports, Vol. 8, Núm. 1